News - details

17 January 2005

Isogenica enters into research collaboration with NeuroTargets Ltd.

Isogenica and NeuroTargets have signed an agreement for the discovery of stable peptide agonists of a GPCR receptor which has potential utility for the treatment of neuropathic pain.